Completed PHASE4 INTERVENTIONAL 2-arm NCT02413554

Rivastigmine Patch Effect on the Post-operative Delirium in Patients at Risk of Dementia.

Rivastigmine Patch Effect on the Post-operative Delirium Limited to Femur Neck Fracture Operation in Patients at Risk of Dementia.

Sponsor: Chung-Ang University Hosptial, Chung-Ang University College of Medicine

Conditions Delirium

Interventions Rivastigmine patch

Updated 5 times since 2017 Last updated: Apr 7, 2015 Started: Apr 30, 2013 Primary completion: Mar 31, 2014 Completion: Apr 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Delirium and is currently completed. Chung-Ang University Hosptial, Chung-Ang University College of Medicine leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chung-Ang University Hosptial, Chung-Ang University College of Medicine

Data source: Chung-Ang University Hosptial, Chung-Ang University College of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.